Seelos Therapeutics Inc (SEEL)
0.5401
-0.18
(-24.99%)
USD |
OTCM |
Nov 15, 16:00
Seelos Therapeutics Price: 0.5401 for Nov. 15, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 15, 2024 | 0.72 | 0.75 | 0.5401 | 0.5401 | 47302.00 |
| Nov 14, 2024 | 0.72 | 0.72 | 0.559 | 0.72 | 10386.00 |
| Nov 13, 2024 | 0.7525 | 0.7525 | 0.70 | 0.70 | 7599.00 |
| Nov 12, 2024 | 0.73 | 0.786 | 0.71 | 0.71 | 15116.00 |
| Nov 11, 2024 | 0.775 | 0.855 | 0.71 | 0.73 | 11886.00 |
| Nov 08, 2024 | 0.70 | 0.79 | 0.70 | 0.7188 | 72076.00 |
| Nov 07, 2024 | 0.70 | 0.89 | 0.67 | 0.70 | 42139.00 |
| Nov 06, 2024 | 0.6805 | 1.00 | 0.68 | 0.6845 | 37877.00 |
| Nov 05, 2024 | 1.10 | 1.10 | 0.6792 | 0.69 | 44168.00 |
| Nov 04, 2024 | 1.02 | 1.20 | 0.90 | 0.92 | 10909.00 |
| Nov 01, 2024 | 1.10 | 1.10 | 1.03 | 1.03 | 5429.00 |
| Oct 31, 2024 | 1.03 | 1.19 | 1.01 | 1.02 | 7703.00 |
| Oct 30, 2024 | 0.95 | 1.20 | 0.95 | 1.10 | 12197.00 |
| Oct 29, 2024 | 1.27 | 1.27 | 0.99 | 0.99 | 16460.00 |
| Oct 28, 2024 | 1.29 | 1.30 | 1.23 | 1.27 | 7222.00 |
| Oct 25, 2024 | 1.15 | 1.34 | 1.15 | 1.22 | 14985.00 |
| Oct 24, 2024 | 1.06 | 1.25 | 1.06 | 1.18 | 5111.00 |
| Oct 23, 2024 | 1.19 | 1.25 | 1.14 | 1.15 | 24955.00 |
| Oct 22, 2024 | 1.25 | 1.33 | 1.14 | 1.20 | 39044.00 |
| Oct 21, 2024 | 1.01 | 1.25 | 1.01 | 1.13 | 25079.00 |
| Oct 18, 2024 | 0.985 | 1.15 | 0.9701 | 1.01 | 51124.00 |
| Oct 17, 2024 | 1.00 | 1.15 | 0.9001 | 1.01 | 128134.0 |
| Oct 16, 2024 | 1.21 | 1.28 | 0.82 | 1.17 | 318139.0 |
| Oct 15, 2024 | 1.46 | 1.574 | 1.15 | 1.28 | 1.697M |
| Oct 14, 2024 | 2.46 | 2.54 | 2.34 | 2.45 | 113031.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
0.5401
Minimum
Nov 15 2024
24268.80
Maximum
Apr 28 2021
4329.40
Average
3478.27
Median
Price Benchmarks
| Cassava Sciences Inc | 26.91 |
| Cara Therapeutics Inc | 0.3111 |
| Citius Pharmaceuticals Inc | 0.20 |
| Moleculin Biotech Inc | 2.71 |
| 180 Life Sciences Corp | 2.50 |
Price Related Metrics
| PS Ratio | 0.0098 |
| Earnings Yield | -88.04K% |
| Market Cap | 0.2355M |